Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Gulou, Fuzhou 350001, Fujian Province, China.
Reproductive Medicine Center, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Gulou, Fuzhou 350001, Fujian Province, China.
Aging (Albany NY). 2021 Jan 11;13(1):1488-1497. doi: 10.18632/aging.202477.
A family with a history of Pelizaeus-Merzbacher disease (PMD) received prenatal diagnosis of gene duplication in a fetus using a single nucleotide polymorphism (SNP) array. A 27-year-old pregnant woman was referred for genetic counseling due to her four-year-old son being diagnosed with a suspected classic type of PMD. Amniocentesis was performed at 18 and 3/7 weeks of gestation, and the SNP array was carried out on DNA from the mother, her affected son, and fetus, then further confirmed by multiplex ligation-dependent probe amplification (MLPA). Cytogenetic analysis of the fetus showed 46,XY. SNP array analysis revealed that the male fetus did not carry gene duplication but the affected boy did, and the mother was a carrier for the duplication of the gene. All SNP array results were further confirmed by MLPA. SNP array and MLPA analyses of peripheral blood verified the nonduplication of the gene in the infant after birth. At present, the child (without duplication) is developing normally. This study preliminarily suggests that SNP array is a sensitive and accurate technology for identifying duplication and is feasible for reliable diagnosis, including for the prenatal diagnosis of PMD resulting from duplication.
一个有 Pelizaeus-Merzbacher 病(PMD)家族史的家庭,通过单核苷酸多态性(SNP)阵列对胎儿进行了基因重复的产前诊断。一位 27 岁的孕妇因 4 岁儿子被诊断为疑似经典型 PMD 而接受遗传咨询。在妊娠 18 周零 3 天进行了羊膜穿刺术,并对来自母亲、受影响的儿子和胎儿的 DNA 进行了 SNP 阵列分析,然后通过多重连接依赖性探针扩增(MLPA)进一步确认。胎儿的细胞遗传学分析显示为 46,XY。SNP 阵列分析显示,男性胎儿未携带 基因重复,但受影响的男孩携带该重复,母亲则是该 基因重复的携带者。所有 SNP 阵列结果均通过 MLPA 进一步确认。出生后对婴儿外周血的 SNP 阵列和 MLPA 分析证实了 基因未发生重复。目前,该患儿(无重复)发育正常。本研究初步表明,SNP 阵列是一种敏感、准确的识别 基因重复的技术,对于包括 基因重复引起的 PMD 的产前诊断在内的可靠诊断是可行的。